In this report, we could demonstrate that significantly smaller proportions of CD4+FOXP3+ cells are present in RA BM in comparison with OA BM and that there are significantly fewer Tregs in BM as compared to blood from the same patient (in OA and RA patient groups). This evidence concerns the gene CD4 and rheumatoid arthritis.